Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Varsha Parulekar"'
Autor:
Dhiraj Agarwal, Sourav Paul, Pallavi Lele, Vikrant Piprode, Anand Kawade, Neerja Hajela, Ashish Bavdekar, Varsha Parulekar, Manisha Ginde, Gandhali Paranjape, Kazunori Matsuda, Tetsuji Hori, Sanjay Juvekar, Girdhari Lal
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-12 (2022)
Abstract Several factors including sex and lifestyle have been reported to contribute to the age-related alteration of immune functions. The study was undertaken to determine age-related differences in the proportion of peripheral blood mononuclear l
Externí odkaz:
https://doaj.org/article/f6566ac5a0dd47d39212d892e7d7afbb
Autor:
Chetan E Chitnis, Paushali Mukherjee, Shantanu Mehta, Syed Shams Yazdani, Shikha Dhawan, Ahmad Rushdi Shakri, Rukmini Bhardwaj, Puneet Kumar Gupta, Dhiraj Hans, Suman Mazumdar, Bijender Singh, Sanjeev Kumar, Gaurav Pandey, Varsha Parulekar, Nathalie Imbault, Preethi Shivyogi, Girish Godbole, Krishna Mohan, Odile Leroy, Kavita Singh, Virander S Chauhan
Publikováno v:
PLoS ONE, Vol 10, Iss 9, p e0137816 (2015)
[This corrects the article DOI: 10.1371/journal.pone.0117820.].
Externí odkaz:
https://doaj.org/article/e01ccae31fed49caaa06c31004ab4694
Autor:
Chetan E Chitnis, Paushali Mukherjee, Shantanu Mehta, Syed Shams Yazdani, Shikha Dhawan, Ahmad Rushdi Shakri, Rukmini Bhardwaj, Puneet Kumar Gupta, Dhiraj Hans, Suman Mazumdar, Bijender Singh, Sanjeev Kumar, Gaurav Pandey, Varsha Parulekar, Nathalie Imbault, Preethi Shivyogi, Girish Godbole, Krishna Mohan, Odile Leroy, Kavita Singh, Virander S Chauhan
Publikováno v:
PLoS ONE, Vol 10, Iss 4, p e0117820 (2015)
A phase I randomised, controlled, single blind, dose escalation trial was conducted to evaluate safety and immunogenicity of JAIVAC-1, a recombinant blood stage vaccine candidate against Plasmodium falciparum malaria, composed of a physical mixture o
Externí odkaz:
https://doaj.org/article/bc6097f8c7bc4aeaaaa19dc564f5151d
Autor:
Ritabrata Kundu, Sanjay Lalwani, Smita Priyadarshan Jategaonkar, Asha Hegde, Gagandeep Kang, Veena G Kamath, Nidhi Goyal, Prabal Niyogi, Sonali Palkar, Varsha Parulekar, Jagdish Kamalaji Zade, Neeta Hanumante, Rakesh Patil, Ashish Bavdekar, Bishan S Garg, Kheya Ghosh Uttam, N. K. Ganguly, Chandra Mohan Kumar, Sajjad Desai, Sudhir Babji, Dutta Gaikwad, Abhijeet Dharmadhikari, Dinesh M Nayak, Padmasani Venkatramanan, Sanjay Juvekar, Abhishek V Raut, Nidhi Bedi, Subodh S Gupta, Chetna Maliye, Mohd. Aslam, Muralidhar M Kulkarni, Girish Dayma, Anand Kawade, Prasad S. Kulkarni, Alok Arya
Publikováno v:
Vaccine. 37:2554-2560
A lyophilized bovine-human rotavirus reassortant pentavalent vaccine (BRV-PV, Rotasiil®) was licensed in 2016. A liquid formulation of this vaccine (LBRV-PV, Rotasiil - Liquid) was subsequently developed and was tested for non-inferiority to Rotasii
Autor:
Nithya J Gogtay, Prasad S. Kulkarni, Peter S. Cheslock, Rajeev M. Dhere, Varsha Parulekar, B J Mahendra, D H Ashwath Narayana, B R Harish, William C. Blackwelder, Deborah C. Molrine, Renuka Munshi, Dipti Kumbhar, Sambhaji Shankar Pisal, Sunil Karande, Saket J. Thaker, Vikas D. Kshirsagar, Bhagwat Gunale, H S Ravish, Siddharth P Deshpande, Susan M. Moore
Publikováno v:
Clinical Infectious Diseases. 66:387-395
Background Lack of access to rabies immunoglobulin (RIG) contributes to high rabies mortality. A recombinant human monoclonal antibody (SII RMAb) was tested in a postexposure prophylaxis (PEP) regimen in comparison with a human RIG (HRIG)-containing
Autor:
Richard A. Adegbola, Julie Chaumont, Aldiouma Diallo, Marc LaForce, Elisa Marchetti, Cheryl M. Elie, Yuxiao Tang, Prasad S. Kulkarni, Godwin Enwere, Brian D. Plikaytis, Simonetta Viviani, Sanjay Juvekar, Varsha Parulekar, Ray Borrow, Fatoumata Diallo, Siddhivinayak Hirve, Olubukola T. Idoko, Lionel Martellet, Milagritos D. Tapia, Bou Diarra, Fadima Cheick Haidara, Helen Findlow, Marie-Pierre Preziosi, Ashish Bavdekar, Adebayo Akinsola, George M. Carlone, Samba O. Sow
Publikováno v:
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
Background. Mass vaccination campaigns of the population aged 1–29 years with 1 dose of group A meningococcal (MenA) conjugate vaccine (PsA-TT, MenAfriVac) in African meningitis belt countries has resulted in the near-disappearance of MenA. The vac
Autor:
Prasad S, Kulkarni, Sajjad, Desai, Tushar, Tewari, Anand, Kawade, Nidhi, Goyal, Bishan Swarup, Garg, Dinesh, Kumar, Suman, Kanungo, Veena, Kamat, Gagandeep, Kang, Ashish, Bavdekar, Sudhir, Babji, Sanjay, Juvekar, Byomkesh, Manna, Shanta, Dutta, Rama, Angurana, Deepika, Dewan, Abhijeet, Dharmadhikari, Jagdish K, Zade, Rajeev M, Dhere, Alan, Fix, Maureen, Power, Vidyasagar, Uprety, Varsha, Parulekar, Iksung, Cho, Temsunaro R, Chandola, Vikash K, Kedia, Abhishek, Raut, Jorge, Flores, Chythra V, Raj
Publikováno v:
Vaccine
Highlights • Pentavalent reassortant rotavirus vaccine was tested for efficacy in infants. • The vaccine (BRV-PV) showed excellent tolerability and a good safety profile. • Primary analysis efficacy was 36% against SRVGE and up to 60.5% against
Autor:
Helen Findlow, F. Marc LaForce, Marie-Pierre Preziosi, Fadima Cheick Haidara, Brian D. Plikaytis, Julie Chaumont, Milagritos D. Tapia, Prasad S. Kulkarni, Varsha Parulekar, Godwin Enwere, Simonetta Viviani, Fatoumata Diallo, Olubukola T. Idoko, Elisa Marchetti, Cheryl M. Elie, Adebayo Akinsola, Yuxiao Tang, George M. Carlone, Samba O. Sow, Beate Kampmann, Moussa Doumbia, Richard A. Adegbola, Ray Borrow, Lionel Martellet
Publikováno v:
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
The “meningitis belt” of sub-Saharan Africa runs across the continent from Senegal to Ethiopia, and this region is prone to major epidemics of meningococcal meningitis, with a high case fatality rate and serious sequelae. Until recently, most epi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::99d44d26a1e8cb845e6ead95ad38195a
Autor:
Varsha Parulekar, Yuxiao Tang, Prasad S. Kulkarni, Milagritos D. Tapia, Marie-Pierre Preziosi, Lionel Martellet, Fatoumata Diallo, Jacques Herve, Julie Chaumont, Samba O. Sow, Fadima Cheick Haidara, Enricke Bouma, Gandhali Paranjape, Moussa Doumbia, Katharina Hartmann, Brian D. Plikaytis, Godwin Enwere
Publikováno v:
Clinical Infectious Diseases, 61
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
Clinical Infectious Diseases, 61
ISSN:1058-4838
ISSN:1537-6591
ISSN:1058-4838
ISSN:1537-6591
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::725fe3be53d4b81e5843ecfcecbe0222
https://hdl.handle.net/20.500.11850/107528
https://hdl.handle.net/20.500.11850/107528
Autor:
Elisa Marchetti, Richard A. Adegbola, Pascal Arduin, Marie-Pierre Préziosi, Helen Findlow, Varsha Parulekar, Simonetta Viviani, Cheryl M. Elie, Fatoumata Diallo, Julie Chaumont, Brian D. Plikaytis, F. Marc LaForce, Doudou Diop, Ray Borrow, Adebayo Akinsola, Prasad S. Kulkarni, Brown J. Okoko, Olubukola T. Idoko, Yuxiao Tang, George M. Carlone, Lionel Martellet, Milagritos D. Tapia, Samba O. Sow, Aldiouma Diallo, Fadima Cheick Haidara
Publikováno v:
New England Journal of Medicine. 364:2293-2304
Background Group A meningococci are the source of major epidemics of meningitis in Africa. An affordable, highly immunogenic meningococcal A conjugate vaccine is needed. Methods We conducted two studies in Africa to evaluate a new MenA conjugate vacc